2019
DOI: 10.1016/j.surg.2019.08.001
|View full text |Cite
|
Sign up to set email alerts
|

Opioid tolerance impacts compliance with enhanced recovery pathway after major abdominal surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 11 publications
0
7
0
Order By: Relevance
“…In this study, a patient was deemed "opioid-tolerant" if he or she was taking an opioid regimen equivalent to 60 mg of daily oral morphine for at least one week prior to surgery. The consequences of opioid tolerance include poorly-controlled pain, which in itself, can lead to decreased compliance with ERAS protocols [8].…”
Section: Review the Chronic Pain Patientmentioning
confidence: 99%
See 3 more Smart Citations
“…In this study, a patient was deemed "opioid-tolerant" if he or she was taking an opioid regimen equivalent to 60 mg of daily oral morphine for at least one week prior to surgery. The consequences of opioid tolerance include poorly-controlled pain, which in itself, can lead to decreased compliance with ERAS protocols [8].…”
Section: Review the Chronic Pain Patientmentioning
confidence: 99%
“…This early intervention during follow up has the potential to reduce the healthcare burden associated with unnecessary visits to urgent care and emergency rooms [2]. The recommendation is promising given studies that have shown that poor compliance may be one of the factors contributing to less favorable outcomes in chronic pain patients [8]. In fact, it has been demonstrated that appropriate adherence to an ERAS protocol can alone significantly reduce postoperative complications and risk of readmission [3].…”
Section: Approach To Carementioning
confidence: 99%
See 2 more Smart Citations
“…Pain control and treatment adherence in opioid-tolerant patients (defined as those who have received at least 60 morphine milligram equivalents (MME) for at least 1 week) [ 12 ], are particularly challenging [ 13 , 14 ]. Whether pharmacist-led management can increase treatment adherence in opioid-tolerant patients with cancer pain is unclear.…”
Section: Introductionmentioning
confidence: 99%